About SANUWAVE Health (OTCMKTS:SNWV)
SANUWAVE Health, Inc. is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures. Its lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, enabling to restore the body's normal healing processes and regeneration. It is focused on developing its Pulsed Acoustic Cellular Expression (PACE) technology to activate healing in wound conditions.
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Trailing P/E Ratio-6.5625
Forward P/E Ratio-8.63
Sales & Book Value
Annual Sales$1.38 million
Price / Sales26.11
Price / CashN/A
Book Value($0.05) per share
Price / Book-5.18
Return on EquityN/A
Return on Assets-666.33%
SANUWAVE Health (OTCMKTS:SNWV) Frequently Asked Questions
What is SANUWAVE Health's stock symbol?
SANUWAVE Health trades on the OTCMKTS under the ticker symbol "SNWV."
How were SANUWAVE Health's earnings last quarter?
SANUWAVE Health, Inc. (OTCMKTS:SNWV) posted its earnings results on Monday, November, 20th. The company reported ($0.01) EPS for the quarter, hitting analysts' consensus estimates of ($0.01). The firm had revenue of $0.16 million for the quarter, compared to analyst estimates of $0.48 million. View SANUWAVE Health's Earnings History.
When will SANUWAVE Health make its next earnings announcement?
Who are some of SANUWAVE Health's key competitors?
Some companies that are related to SANUWAVE Health include Aptevo Therapeutics (APVO), Catasys (CATS), Joint (JYNT), Axsome Therapeutics (AXSM), Applied Genetic Technologies (AGTC), Xenon Pharmaceuticals (XENE), Histogenics (HSGX), Arcturus Therapeutics (ARCT), Versartis (VSAR), PLx Pharma (PLXP), Arch Therapeutics (ARTH), IntelGenx Technologies (IGXT), Opiant Pharmaceuticals (OPNT), Presbia (LENS), PURE Bioscience (PURE), Cardiome Pharma (CRME), Acerus Pharmaceuti (TRLPF) and Digirad (DRAD).
Who are SANUWAVE Health's key executives?
SANUWAVE Health's management team includes the folowing people:
- Kevin A. Richardson II, Chairman of the Board, Co-Chief Executive Officer (Age 46)
- Lisa E. Sundstrom, Chief Financial Officer (Age 45)
- Maj-Britt Kaltoft, Director
- John Fritzen Nemelka, Director (Age 49)
- A. Michael Stolarski, Director
- Alan L. Rubino, Independent Director (Age 60)
How do I buy SANUWAVE Health stock?
Shares of SANUWAVE Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is SANUWAVE Health's stock price today?
One share of SANUWAVE Health stock can currently be purchased for approximately $0.26.
How big of a company is SANUWAVE Health?
SANUWAVE Health has a market capitalization of $35.51 million and generates $1.38 million in revenue each year. The company earns $-6,430,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. SANUWAVE Health employs 6 workers across the globe.
How can I contact SANUWAVE Health?
SANUWAVE Health's mailing address is 3360 Martin Farm Road Suite 100, Suwanee GA, 30024. The company can be reached via phone at 770-419-7525 or via email at [email protected]
MarketBeat Community Rating for SANUWAVE Health (SNWV)MarketBeat's community ratings are surveys of what our community members think about SANUWAVE Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
SANUWAVE Health (OTCMKTS:SNWV) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
SANUWAVE Health (OTCMKTS:SNWV) Earnings History and Estimates Chart
SANUWAVE Health (OTCMKTS SNWV) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/3/2018|| || || || || || || || |
|11/20/2017||Q3 2017||($0.01)||($0.01)||$0.48 million||$0.16 million||View||N/A|
|8/14/2017||Q2 2017||($0.01)||($0.01)||$0.24 million||$0.11 million||View||N/A|
|8/6/2014||($0.04)||($0.03)||$0.20 million||$0.24 million||View||N/A|
SANUWAVE Health (OTCMKTS:SNWV) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $-0.02 EPS
Dividend History for SANUWAVE Health (OTCMKTS:SNWV)
No dividend announcements for this company have been tracked by MarketBeat.com
SANUWAVE Health (OTCMKTS SNWV) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 23.40%
Institutional Ownership Percentage: 0.47%
SANUWAVE Health (OTCMKTS SNWV) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/28/2016||Anthony Michael Stolarski||Director||Buy||500,000||$0.06||$30,000.00||3,724,626|| |
|3/17/2014||Joseph Chiarelli||CEO||Buy||80,000||$0.50||$40,000.00|| |
|3/17/2014||Kevin A Richardson II||Director||Buy||100,000||$0.50||$50,000.00|| |
|10/9/2013||Joseph Chiarelli||CEO||Buy||41,667||$0.60||$25,000.20|| |
|10/9/2013||Kevin A Richardson II||Director||Buy||35,312||$0.60||$21,187.20|| |
|9/19/2013||Barry J Jenkins||CFO||Buy||13,500||$0.74||$9,990.00|| |
|8/13/2013||Christopher M Cashman||Major Shareholder||Sell||33,500||$0.77||$25,795.00|| |
|6/11/2013||Christopher M Cashman||Major Shareholder||Sell||34,800||$0.80||$27,840.00|| |
|6/6/2013||Christopher M Cashman||Major Shareholder||Sell||46,100||$0.89||$41,029.00|| |
|5/29/2013||Christopher M Cashman||Major Shareholder||Sell||2,827||$0.84||$2,374.68|| |
|5/22/2013||Christopher M Cashman||Major Shareholder||Sell||73,461||$0.96||$70,522.56|| |
|5/17/2013||Christopher M Cashman||Major Shareholder||Sell||26,539||$1.00||$26,539.00|| |
|11/27/2012||David Nephi Jr. Nemelka||Major Shareholder||Buy||4,000,000||$0.25||$1,000,000.00|| |
SANUWAVE Health (OTCMKTS SNWV) News Headlines
SANUWAVE Health (OTCMKTS:SNWV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
SANUWAVE Health (OTCMKTS SNWV) Stock Chart for Wednesday, February, 21, 2018